BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16503318)

  • 61. Generic and therapeutic statin switches and disruptions in therapy.
    Chapman RH; Benner JS; Girase P; Benigno M; Axelsen K; Liu LZ; Nichol MB
    Curr Med Res Opin; 2009 May; 25(5):1247-60. PubMed ID: 19344292
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sex Differences in the Use of Statins in Community Practice.
    Nanna MG; Wang TY; Xiang Q; Goldberg AC; Robinson JG; Roger VL; Virani SS; Wilson PWF; Louie MJ; Koren A; Li Z; Peterson ED; Navar AM
    Circ Cardiovasc Qual Outcomes; 2019 Aug; 12(8):e005562. PubMed ID: 31416347
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association of copayment and statin adherence stratified by socioeconomic status.
    Kazerooni R; Bounthavong M; Watanabe JH
    Ann Pharmacother; 2013 Nov; 47(11):1463-70. PubMed ID: 24259605
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Postdischarge lipid management of coronary artery disease patients according to the new National Cholesterol Education Program guidelines.
    Hunninghake DB
    Am J Cardiol; 2001 Oct; 88(8A):37K-41K. PubMed ID: 11694218
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Statin prescribing in the elderly in the Netherlands: a pharmacy database time trend study.
    Geleedst-De Vooght M; Maitland-van der Zee AH; Schalekamp T; Mantel-Teeuwisse A; Jansen P
    Drugs Aging; 2010 Jul; 27(7):589-96. PubMed ID: 20583852
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Does a cardiovascular event change adherence to statin treatment in patients with type 2 diabetes? A matched cohort design.
    de Vries FM; Denig P; Vegter S; Bos HJ; Postma MJ; Hak E
    Curr Med Res Opin; 2015 Apr; 31(4):595-602. PubMed ID: 25629791
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Influence of physicians' subspecialty and training history on CKD management and medical cooperation: from the results of a nationwide questionnaire survey for primary care physicians].
    Naito T; Ohtani H; Kobayashi K; Miyazaki M; Yamada K; Sugawara M; Naka Y; Saruta T
    Nihon Jinzo Gakkai Shi; 2013; 55(8):1401-11. PubMed ID: 24568037
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Interventions to Improve Statin Tolerance and Adherence in Patients at Risk for Cardiovascular Disease : A Systematic Review for the 2020 U.S. Department of Veterans Affairs and U.S. Department of Defense Guidelines for Management of Dyslipidemia.
    Reston JT; Buelt A; Donahue MP; Neubauer B; Vagichev E; McShea K
    Ann Intern Med; 2020 Nov; 173(10):806-812. PubMed ID: 32956601
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Statin treatment patterns and clinical profile of patients with risk factors for coronary heart disease defined by National Cholesterol Education Program Adult Treatment Panel III.
    Kern DM; Balu S; Tunceli O; Anzalone D
    Curr Med Res Opin; 2014 Dec; 30(12):2443-51. PubMed ID: 25280070
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registry.
    Nanna MG; Navar AM; Wang TY; Li S; Virani SS; Li Z; Robinson JG; Roger VL; Wilson PWF; Goldberg AC; Koren A; Louie MJ; Peterson ED
    Am Heart J; 2019 Aug; 214():113-124. PubMed ID: 31202098
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Delay in filling the initial prescription for a statin: a potential early indicator of medication nonpersistence.
    Yu AP; Yu YF; Nichol MB; Gwadry-Sridhar F
    Clin Ther; 2008 Apr; 30(4):761-74; discussion 716. PubMed ID: 18498924
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of Statin Prescribing for Secondary Prevention in Primary Care Following New Guideline Recommendations.
    Zupec JF; Marrs JC; Saseen JJ
    Ann Pharmacother; 2016 Jan; 50(1):17-21. PubMed ID: 26416950
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Visualizing coronary calcium is associated with improvements in adherence to statin therapy.
    Kalia NK; Miller LG; Nasir K; Blumenthal RS; Agrawal N; Budoff MJ
    Atherosclerosis; 2006 Apr; 185(2):394-9. PubMed ID: 16051253
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry.
    Virani SS; Kennedy KF; Akeroyd JM; Morris PB; Bittner VA; Masoudi FA; Stone NJ; Petersen LA; Ballantyne CM
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e004652. PubMed ID: 29748356
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice.
    Arca M; Ansell D; Averna M; Fanelli F; Gorcyca K; Iorga ŞR; Maggioni AP; Paizis G; Tomic R; Catapano AL
    Atherosclerosis; 2018 Apr; 271():120-127. PubMed ID: 29499359
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Use and monitoring of "statin" lipid-lowering drugs compared with guidelines.
    Abookire SA; Karson AS; Fiskio J; Bates DW
    Arch Intern Med; 2001 Jan; 161(1):53-8. PubMed ID: 11146698
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Differences in statin utilization and lipid lowering by race, ethnicity, and HIV status in a real-world cohort of persons with human immunodeficiency virus and uninfected persons.
    Riestenberg RA; Furman A; Cowen A; Pawlowksi A; Schneider D; Lewis AA; Kelly S; Taiwo B; Achenbach C; Palella F; Stone NJ; Lloyd-Jones DM; Feinstein MJ
    Am Heart J; 2019 Mar; 209():79-87. PubMed ID: 30685678
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Can guidelines impact the ordering of magnetic resonance imaging studies by primary care providers for low back pain?
    Rao JK; Kroenke K; Mihaliak KA; Eckert GJ; Weinberger M
    Am J Manag Care; 2002 Jan; 8(1):27-35. PubMed ID: 11814170
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Compliance to recommended liver function monitoring in patients on statin therapy.
    Leaver H; Keng Lim T; Thomson P; Leaver J; Choy AM; Lang CC
    Cardiovasc Ther; 2009; 27(2):96-100. PubMed ID: 19426246
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
    Rodriguez F; Maron DJ; Knowles JW; Virani SS; Lin S; Heidenreich PA
    JAMA Cardiol; 2017 Jan; 2(1):47-54. PubMed ID: 27829091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.